William E. Barlow

31.7k total citations · 4 hit papers
277 papers, 19.9k citations indexed

About

William E. Barlow is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William E. Barlow has authored 277 papers receiving a total of 19.9k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Oncology, 57 papers in Cancer Research and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William E. Barlow's work include Global Cancer Incidence and Screening (68 papers), Breast Cancer Treatment Studies (46 papers) and Colorectal Cancer Screening and Detection (35 papers). William E. Barlow is often cited by papers focused on Global Cancer Incidence and Screening (68 papers), Breast Cancer Treatment Studies (46 papers) and Colorectal Cancer Screening and Detection (35 papers). William E. Barlow collaborates with scholars based in United States, Canada and United Kingdom. William E. Barlow's co-authors include Laura Ichikawa, Richard A. Deyo, Daniel C. Cherkin, Stephen H. Taplin, Karla Kerlikowske, Patricia A. Carney, Andrea Z. LaCroix, Michael VonKorff, Gregory E. Simon and Janet Street and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

William E. Barlow

269 papers receiving 19.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exercise Plus Behavioral Management in Patients With Alzheimer Disease

2003 576 citations William E. Barlow et al. profile →
Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

2007 558 citations William E. Barlow et al. Journal of Clinical Oncology profile →
Analysis of Case-Cohort Designs

1999 534 citations William E. Barlow et al. profile →
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

2014 482 citations Jeffrey B. Smerage, William E. Barlow et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by William E. Barlow

Since Specialization

Citations

This map shows the geographic impact of William E. Barlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Barlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Barlow more than expected).

Fields of papers citing papers by William E. Barlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Barlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Barlow. The network helps show where William E. Barlow may publish in the future.

Co-authorship network of co-authors of William E. Barlow

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Barlow. A scholar is included among the top collaborators of William E. Barlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Barlow. William E. Barlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Postneoadjuvant Prognostic Breast Cancer Staging System 2025 ·Journal of Clinical Oncology ·David J. Winchester, (unknown), Stephen B. Edge, Kimberly H. Allison, William E. Barlow, Veerle Bossuyt, Mariana Chávez‐MacGregor, Emily F. Conant, James L. Connolly, Jennifer F. De Los Santos, (unknown), (unknown), Elizabeth A. Mittendorf, Jennifer K. Plichta, Elena Provenzano, Kilian Salerno, (unknown), (unknown), Donald L. Weaver, Gabriel N. Hortobágyi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
2	Long-Term Adverse Effects and Complications After Prostate Cancer Treatment 2024 ·JAMA Oncology ·Joseph M. Unger, Cathee Till, Catherine M. Tangen, Dawn L. Hershman, Phyllis J. Goodman, Michael LeBlanc, William E. Barlow, Riha Vaidya, Lori M. Minasian, Howard L. Parnes, Ian M. Thompson	9
3	TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy 2024 ·Therapeutic Advances in Medical Oncology ·Aditya Bardia, Lajos Pusztai, Kathy S. Albain, Eva Ciruelos, Seock‐Ah Im, Dawn L. Hershman, Kevin Kalinsky, Claudine Isaacs, Delphine Loirat, Laura Testa, Eriko Tokunaga, Jiong Wu, Hannah Dry, William E. Barlow, Robert Kozarski, Micah J. Maxwell, Nadia Harbeck, Priyanka Sharma	16
4	Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials 2024 ·JAMA Network Open ·Dawn L. Hershman, Riha Vaidya, Cathee Till, William E. Barlow, (unknown), Scott D. Ramsey, Joseph M. Unger	5
5	Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221 2023 ·Journal of the National Comprehensive Cancer Network ·(unknown), Gary Zirpoli, William E. Barlow, G. Thomas Budd, (unknown), Lajos Pusztai, Gabriel N. Hortobágyi, Kathy S. Albain, M. Imad Damaj, Andrew K. Godwin, Alastair M. Thompson, N. Lynn Henry, Christine B. Ambrosone, Kathleen A. Stringer, Daniel L. Hertz	15
6	Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial 2023 ·JAMA Oncology ·Reshma Jagsi, William E. Barlow, Wendy A. Woodward, Eileen P. Connolly, Reshma Mahtani, Dean A. Shumway, Corey Speers, Shane R. Stecklein, Youssef H. Zeidan, Hong Zhang, Priyanka Sharma, Lajos Pusztai, Gabriel N. Hortobágyi, Kevin Kalinsky	6
7	Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening 2023 ·Journal of General Internal Medicine ·Tracy Onega, (unknown), Elisabeth F. Beaber, Jennifer S. Haas, Erica S. Breslau, Anna N.A. Tosteson, Ethan A. Halm, Chun Chao, William E. Barlow	3
8	Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing 2023 ·JCO Oncology Practice ·Dawn L. Hershman, Aasthaa Bansal, William E. Barlow, Kathryn B. Arnold, Kate Watabayashi, (unknown), Sean D. Sullivan, Gary H. Lyman, Scott D. Ramsey	1
9	An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD 2022 ·Journal of Comparative Effectiveness Research ·(unknown), Kate Watabayashi, Karma L. Kreizenbeck, (unknown), Aasthaa Bansal, William E. Barlow, Gary H. Lyman, Dawn L. Hershman, (unknown), (unknown), (unknown), Jamie Myers, (unknown), (unknown), (unknown), (unknown), Jeffrey Crawford, Sean D. Sullivan	1
10	A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia 2022 ·Journal of Clinical Oncology ·Dawn L. Hershman, Aasthaa Bansal, Sean D. Sullivan, William E. Barlow, Kathryn B. Arnold, Kate Watabayashi, (unknown), Nguyet Le‐Lindqwister, (unknown), Ursa Brown‐Glaberman, Robert J. Behrens, Victor G. Vogel, (unknown), Scott D. Ramsey	3
11	Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome 2020 ·Clinical Cancer Research ·Ryan L. Powles, Vikram B. Wali, Xiaotong Li, William E. Barlow, Zeina Nahleh, Alastair M. Thompson, Andrew K. Godwin, Christos Hatzis, Lajos Pusztai	9
12	Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials 2020 ·Breast Cancer Research and Treatment ·Dawn L. Hershman, Cathee Till, Jason D. Wright, Melissa Accordino, Riha Vaidya, William E. Barlow, Scott D. Ramsey, Joseph M. Unger	5
13	Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study 2019 ·Clinical Cancer Research ·Costanza Paoletti, Jieling Miao, (unknown), Elizabeth P. Darga, Madeline Repollet, Gerald V. Doyle, Julie R. Gralow, Gabriel N. Hortobágyi, Jeffrey B. Smerage, William E. Barlow, Daniel F. Hayes	57
14	Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER–Medicare Population 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Lü Chen, Jessica Chubak, Denise M. Boudreau, William E. Barlow, Noel S. Weiss, Christopher I. Li	27
15	Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis 2017 ·Cancer Research ·Lu Chen, Jessica Chubak, Denise M. Boudreau, William E. Barlow, Noel S. Weiss, Christopher I. Li	32
16	Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium 2016 ·Breast Cancer Research and Treatment ·Emily F. Conant, Elisabeth F. Beaber, Brian L. Sprague, Sally D. Herschorn, Donald L. Weaver, Tracy Onega, Anna N.A. Tosteson, Anne Marie McCarthy, Steven P. Poplack, Jennifer S. Haas, Katrina Armstrong, Mitchell D. Schnall, William E. Barlow	146
17	Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Elisabeth F. Beaber, Kathleen E. Malone, Mei-Tzu C. Tang, William E. Barlow, Peggy L. Porter, Janet R. Daling, Christopher I. Li	53
18	American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer 2011 ·Journal of Clinical Oncology ·Catherine Van Poznak, Sarah Temin, Gary C. Yee, Nora A. Janjan, William E. Barlow, J. Sybil Biermann, Linda D. Bosserman, Cindy Geoghegan, Bruce E. Hillner, Richard L. Theriault, Dan Sayam Zuckerman, Jamie H. Von Roenn	235
19	NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. 2010 ·PubMed ·Donald M. Steinwachs, Jennifer D. Allen, William E. Barlow, R. Paul Duncan, Leonard E. Egede, Lawrence S. Friedman, Nancy L. Keating, Paula Kim, Judith R. Lave, Thomas A. LaVeist, Roberta B. Ness, Robert Optican, Beth A Virnig	50
20	Cost-effectiveness of strategies to enhance mammography use. 2001 ·PubMed ·Paul Fishman, Stephen H. Taplin, (unknown), William E. Barlow	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact